BackImmunityBio Overview

ImmunityBio Minority Interest

Track ImmunityBio's minority interest ($870K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Minority Interest
$868000.00
6.67% YoYΔ $-62000.00 vs prior year quarter

Peer average

Loading

ImmunityBio Minority Interest History

Loading

ImmunityBio vs. peers: Minority Interest Comparison

Loading

ImmunityBio Minority Interest Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

ImmunityBio (IBRX) FAQ

The latest minority interest for IBRX is $870K as of June 2026. That compares with $930K in the prior-year period — down 6.7% year over year. Investors often review this figure alongside ImmunityBio's historical trend and sector peers before judging valuation or financial health.

Over the past year, IBRX's minority interest moved from $930K to $870K — a 6.7% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in ImmunityBio's operating scale or balance-sheet position.

A minority interest figure of $870K for IBRX is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting IBRX's minority interest ($870K), review year-over-year change from $930K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack ImmunityBio's minority interest against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.